Measured Risk Portfolios Inc. Has $1.49 Million Stock Holdings in The Clorox Company $CLX

Measured Risk Portfolios Inc. increased its position in shares of The Clorox Company (NYSE:CLX) by 6.7% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 12,388 shares of the company’s stock after purchasing an additional 778 shares during the quarter. Measured Risk Portfolios Inc.’s holdings in Clorox were worth $1,487,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in the company. Vanguard Group Inc. increased its position in shares of Clorox by 0.4% during the 1st quarter. Vanguard Group Inc. now owns 15,573,076 shares of the company’s stock worth $2,293,135,000 after purchasing an additional 65,924 shares in the last quarter. Northern Trust Corp increased its position in shares of Clorox by 2.3% during the 1st quarter. Northern Trust Corp now owns 1,528,920 shares of the company’s stock worth $225,133,000 after purchasing an additional 34,655 shares in the last quarter. Invesco Ltd. increased its position in shares of Clorox by 7.4% during the 1st quarter. Invesco Ltd. now owns 1,361,710 shares of the company’s stock worth $200,512,000 after purchasing an additional 94,371 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in shares of Clorox by 3.7% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,157,257 shares of the company’s stock worth $170,406,000 after purchasing an additional 41,485 shares in the last quarter. Finally, Hsbc Holdings PLC increased its position in shares of Clorox by 118.8% during the 1st quarter. Hsbc Holdings PLC now owns 1,085,661 shares of the company’s stock worth $159,699,000 after purchasing an additional 589,544 shares in the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Insider Activity

In other news, COO Eric H. Reynolds sold 15,041 shares of the firm’s stock in a transaction dated Thursday, September 4th. The shares were sold at an average price of $123.78, for a total value of $1,861,774.98. Following the transaction, the chief operating officer owned 54,221 shares of the company’s stock, valued at approximately $6,711,475.38. This trade represents a 21.72% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 0.57% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on CLX shares. UBS Group dropped their target price on shares of Clorox from $150.00 to $134.00 and set a “neutral” rating for the company in a research report on Thursday, July 17th. Wells Fargo & Company lowered their price objective on shares of Clorox from $130.00 to $125.00 and set an “equal weight” rating for the company in a research report on Thursday, September 25th. Zacks Research upgraded shares of Clorox from a “strong sell” rating to a “hold” rating in a research report on Monday, September 29th. Citigroup restated a “neutral” rating and issued a $135.00 price objective (down previously from $140.00) on shares of Clorox in a research report on Tuesday, July 15th. Finally, Morgan Stanley lowered their price objective on shares of Clorox from $150.00 to $137.00 and set an “equal weight” rating for the company in a research report on Friday, August 1st. One research analyst has rated the stock with a Buy rating, ten have assigned a Hold rating and three have given a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Reduce” and a consensus price target of $134.08.

Clorox Stock Up 0.9%

Shares of NYSE CLX opened at $123.30 on Friday. The firm has a market capitalization of $15.08 billion, a PE ratio of 18.91, a price-to-earnings-growth ratio of 0.99 and a beta of 0.52. The company has a current ratio of 0.84, a quick ratio of 0.57 and a debt-to-equity ratio of 5.15. The Clorox Company has a 1 year low of $116.53 and a 1 year high of $171.37. The firm’s 50-day moving average is $122.81 and its 200-day moving average is $129.53.

Clorox (NYSE:CLX) last issued its earnings results on Thursday, July 31st. The company reported $2.87 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.24 by $0.63. The company had revenue of $1.99 billion for the quarter, compared to analyst estimates of $1.94 billion. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The company’s revenue for the quarter was up 4.5% on a year-over-year basis. During the same quarter last year, the firm earned $1.82 EPS. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. Equities analysts expect that The Clorox Company will post 7.15 EPS for the current year.

Clorox Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, November 6th. Stockholders of record on Wednesday, October 22nd will be paid a $1.24 dividend. This represents a $4.96 annualized dividend and a dividend yield of 4.0%. The ex-dividend date of this dividend is Wednesday, October 22nd. Clorox’s dividend payout ratio (DPR) is 76.07%.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.